Editas Medicine, Inc.
EDIT
$2.73
-$0.0965-3.41%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 21.26% | -22.82% | -140.52% | -38.03% | -67.80% |
| Total Depreciation and Amortization | 29.15% | 36.05% | -5.80% | 5.61% | -7.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 113.96% | 49.21% | 64.39% | 3.76% | -38.78% |
| Change in Net Operating Assets | -172.07% | 266.98% | -49.61% | -4.89% | 245.81% |
| Cash from Operations | 12.00% | 4.16% | -128.25% | -48.31% | -47.41% |
| Capital Expenditure | 100.00% | 93.91% | 58.68% | -1,122.18% | -162.12% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -23.35% | 2,065.94% | -50.90% | 184.71% | 287.34% |
| Cash from Investing | -17.91% | 1,288.35% | -50.74% | 181.68% | 300.20% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,201.86% | 647.40% | -47.67% | -- | -99.73% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,201.86% | -848.44% | 10,700.19% | -- | -99.73% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 96.87% | 113.14% | -13.15% | 122.70% | -105.21% |